Attached files
| file | filename |
|---|---|
| EX-32.2 - CERTIFICATION - Actinium Pharmaceuticals, Inc. | f10q0918ex32-2_actinium.htm |
| EX-31.2 - CERTIFICATION - Actinium Pharmaceuticals, Inc. | f10q0918ex31-2_actinium.htm |
| EX-31.1 - CERTIFICATION - Actinium Pharmaceuticals, Inc. | f10q0918ex31-1_actinium.htm |
| EX-4.3 - AMENDMENT TO ACTINIUM PHARMACEUTICALS, INC. WARRANT TO PURCHASE COMMON STOCK, DA - Actinium Pharmaceuticals, Inc. | f10q0918ex4-3_actinium.htm |
| EX-4.2 - AMENDMENT TO ACTINIUM PHARMACEUTICALS, INC. WARRANT TO PURCHASE COMMON STOCK, DA - Actinium Pharmaceuticals, Inc. | f10q0918ex4-2_actinium.htm |
| EX-4.1 - AMENDMENT TO ACTINIUM PHARMACEUTICALS, INC. WARRANT TO PURCHASE COMMON STOCK, DA - Actinium Pharmaceuticals, Inc. | f10q0918ex4-1_actinium.htm |
| 10-Q - QUARTERLY REPORT - Actinium Pharmaceuticals, Inc. | f10q0918_actiniumpharma.htm |
Exhibit 32.1
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Actinium Pharmaceuticals, Inc. (the “Company”) on Form 10-Q for the period ended September 30, 2018 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Sandesh Seth, Chairman & CEO of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
| 1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and |
| 2. | The information contained in the Quarterly Report fairly presents, in all material respects, the financial condition and result of operations of the Company. |
| Date: November 9, 2018 | By: | /s/ Sandesh Seth |
| Sandesh Seth | ||
|
Chairman & CEO (Duly Authorized Officer and Principal Executive Officer) |